Literature DB >> 27038982

Value of Nephrometry Score Constituents on Perioperative Outcomes and Split Renal Function in Patients Undergoing Minimally Invasive Partial Nephrectomy.

Kara L Watts1, Propa Ghosh2, Solomon Stein2, Reza Ghavamian2.   

Abstract

OBJECTIVE: To assess the relationship between individual nephrometry score (NS) constituents (RENAL) on perioperative outcomes and renal function of the surgical kidney in patients undergoing laparoscopic partial nephrectomy or robotic-assisted partial nephrectomy.
MATERIALS AND METHODS: Two hundred forty-five patients who underwent laparoscopic partial nephrectomy or robotic-assisted partial nephrectomy between 2005 and 2014 were retrospectively reviewed. Each renal mass' NS was calculated from preoperative computed tomography imaging. Multivariate regression analysis was used to evaluate the effect of NS variables on perioperative outcomes and change in overall renal function (as estimated by glomerular filtration rate) from preoperative to 1-year postoperative. A cohort analysis assessed the effect of NS variables on change in split renal function of the surgical kidney from pre- to postoperative based on nuclear medicine renal scintigraphy.
RESULTS: Tumor radius (R), endophytic nature (E), and nearness to collecting system (N) variables significantly and incrementally predicted a longer operative time and warm ischemia time. Overall renal function based on glomerular filtration rate was not affected by any NS variable. However, percent function of the surgical kidney by renal scintigraphy significantly decreased postoperatively as R and E values increased.
CONCLUSION: R, E, and N were associated with significant changes in warm ischemia time and operative time. R and E were associated with a significant decrease in split renal function of the surgical kidney at 1 year after surgery but not with overall renal function. R, E, and N are the NS constituents most relevant to perioperative outcomes and postoperative differential renal function after partial nephrectomy.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2016        PMID: 27038982     DOI: 10.1016/j.urology.2016.01.046

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  Systematic Review of Contemporary Evidence for the Management of T1 Renal Cell Carcinoma: What IRs Need to Know for Kidney Cancer Tumor Boards.

Authors:  Julie Cronan; Sean Dariushnia; Zachary Bercu; Robert Mitchell Ermentrout; Bill Majdalany; Laura Findeiss; Janice Newsome; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2019-08-19       Impact factor: 1.513

2.  Tumor volume and tumor crossing of the axial renal midline predict renal function after robotic partial nephrectomy.

Authors:  Haruyuki Ohsugi; Kyojiro Akiyama; Hisanori Taniguchi; Masaaki Yanishi; Motohiko Sugi; Tadashi Matsuda; Hidefumi Kinoshita
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

Review 3.  Robot-assisted partial nephrectomy: How to minimise renal ischaemia.

Authors:  Chandran Tanabalan; Avi Raman; Faiz Mumtaz
Journal:  Arab J Urol       Date:  2018-07-07

4.  External validation of the Simplified PADUA REnal (SPARE) nephrometry system in predicting surgical outcomes after partial nephrectomy.

Authors:  Chi-Ping Huang; Chao-Hsiang Chang; Hsi-Chin Wu; Che-Rei Yang; Po-Fan Hsieh; Guang-Heng Chen; Po-Jen Hsiao; Yi-Huei Chang; Yu-Ping Wang; Yu-De Wang
Journal:  BMC Urol       Date:  2020-09-11       Impact factor: 2.264

5.  Outcomes of open partial nephrectomy for renal cell carcinoma in the minimally invasive approach era.

Authors:  Kosuke Shibamori; Kohei Hashimoto; Tetsuya Shindo; Hidetoshi Tabata; Yuki Kyoda; Ko Kobayashi; Toshiaki Tanaka; Naoya Masumori
Journal:  Curr Urol       Date:  2021-10-08

6.  Changes in kidney function according to ischemia type during partial nephrectomy for T1a kidney cancer.

Authors:  Junghoon Lee; Young Cheol Hwang; Sangjun Yoo; Min Soo Choo; Min Chul Cho; Hwancheol Son; Hyeon Jeong
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.